Who says you can’t see it all? With a comprehensive view of structural variants and methylation, nanopore technology powers the bigger and bolder research questions you’ve always wanted to ask.
Ask bolder questions.Make no compromises.
With the ability to read any length of DNA or RNA, short to ultra-long, nanopore sequencing captures more genomic variation — including structural variation and methylation — so you can get the context and clarity you need, every time. This comprehensive view powers the bigger and bolder research questions you’ve always wanted to ask. And real-time data means rapid insight to time-critical results, all in a platform that sits on your lab bench.
Get all the rich data you need from sequencing native DNA and RNA molecules in a single platform with access to all of your biology, so you can get a more complex and comprehensive view of the genetics of human disease.
Human genomics
Characterise human genetic variation, close genomic gaps, and generate full-length RNA transcripts. Combining rich genetic data with scalable formats enables whole-genome sequencing, targeted sequencing, transcriptomics and other techniques for new insights into human health and disease.
Generate ultra-rich data for answers with impact.
Direct, amplification-free sequencing eliminates bias and supports simultaneous detection of epigenetic modifications. You get the rich data you need in a single platform with access to all of your biology for a more complex and comprehensive view of the genetics of human disease.
With direct reads see base modifications without extra sample prep. Stay on top of what's next.
Cancer
Discover the diverse genomic factors behind cancer, from single nucleotide variants to epigenetic changes. Nanopore technology enables you to sequence any length of DNA and detect modifications in real-time, for rapid, comprehensive cancer sample analysis.
Reveal the biology that willtransform human health.
From fusions to full-length transcript isoforms, methylation to complex copy number variations, nanopore technology helps you reveal powerful information about underlying causes of disease. Long nanopore sequencing reads confer the ability to identify and phase SNPs, structural variants, and epigenetic modifications, and fully characterise novel isoforms and fusion transcripts.
Take a wider lens on human genomics with technology that powers a more diverse range of experiments.
Scale to suit your needs
Nanopore sequencing is the only sequencing technology to enable real-time analysis in fully scalable formats. From the pocket-sized MinION to the high-throughput, population-scale PromethION — scale nanopore sequencing to suit any experimental needs.
PromethION 2 devices maintain the flexibility associated with the PromethION 24 and PromethION 48 devices, but in a compact, accessible form factor.
Flexible, large-scale sequencing using up to 24 independent, high-capacity flow cells.
Combining up to 48 independently addressable, high-capacity flow cells with powerful, integrated compute, PromethION 48 delivers flexible, on-demand access to terabases of sequencing data.
A compact benchtop device offering powerful integrated compute. Run multiple projects on a single device using five independent MinION Flow Cells and sample multiplexing.
Subscribe
Get in touch
If you have any questions about our products or services, chat directly with a member of our sales team.
To book a call with one of our sales team, please click below.